Wahi Pharmaceuticals

Pipeline

Our product Pipeline projections over the short to medium term.

Product Pipeline

At Wahi Pharmaceuticals, Inc., we are developing a differentiated portfolio of herbal medicine for treating viral infections, mainly for COVID-19, and cancer.

Besides, we are developing an immunomodulator to help patients with many inflammatory autoimmune diseases.

This type of research and development will enable us to pursue multiple indications with the potential to help transform outcomes of patients with various diseases.

Wahipham product development

Product Creation

Wahi Pharmaceuticals is a leading Botanicals Research and Development organization, focused on novel therapeutics, specifically in the areas of immunity, fertility and cancer. We are dedicated to delivering innovative, safe, natural and accessible solutions to improve the quality of patients’ lives and healthcare outcomes.

Recocov™ Is available in two Dosage forms;

  1. Hard gel capsule: 30 capsules per bottle (dosage: 1 capsule 3 times a day for 5 days)
  2. Syrup: 180 ml (dosage: 10 ml 3 times a day for 5 days)

Hard gel capsule is produced in two packages;

  1. Blister
  2. Bottle.
Green bottle of Recocov tablets sitting on green grass, produced by Wahi Pharmaceuticals

More About Our Product

Wahi Pharmaceutical focus on all-natural, accessible therapeutics has translated into Recocov™

  1. Vegan
  2. GMO free
  3. No coloring agents or Diluents
  4. Gluten free
  5. Halal / Kosher
  6. Lab tested
  7. GMP Certified
  8. Alcohol free
  9. BSE free
  10. Does not contain nuts, soy and dairy
Platform Indication
Research
IND Enabling
Clinical Trials
Commercialization
Covid-19 / SARS-CoV-2
Herbal Medicine 25%
Immunomodulator
Herbal Medicine 25%
Cancer
Herbal Medicine 5%
Viral Infections
Herbal Medicine 5%

Extracted from plant sources

Extracted from plant sources